The mission of the Case CCC Gene Expression &Genotyping Facility (GEGF) is to facilitate implementation of high throughput genetic technologies for the research conducted by members of the CWRU community. The GEGF serves as a technical and consulting resource for Cancer Center members, as well as other investigators laboratories at CWRU, UH, CCF, MHMC and the VAMC, in the areas of high throughput expression analysis and genotyping. It is the only facility of its capability in Cleveland. This Facility utilizes Affymetrix and Applied Biosystems (ABI) technologies as well as Next Generation Sequencing (NGS) to provide global and quantitative (on user-identified genes) gene expression analysis services. While the comprehensive and quantitative properties of NGS assays, for both RNA and DNA, now make these technologies an excellent choice for many genomic studies, these approaches are still very expensive and require extensive informatics expertise for generation of useful data. Therefore, the demand for microarray technology and real time PCR to identify global changes in gene expression and genetic variants in populations has remained at undiminished levels over the past several years. Microarrays have the distinct advantage of providing economical, rapid and readily accessible data that is generically comprehensive in scope, without an overwhelming requirement for computer capacity or informatics expertise. An important service provided by the GEGF, however, is provision of advice to individual investigators on the comparative limits and applicability of the broad range of available technologies for assessment of gene expression and genomic applications. Approximately 60 investigators use the GEGF every year and 30-50% of these are first time users, documenting that the GEGF continues to enjoy a healthy level of growth and a robust level of sustained work with repeat users. Since the last competitive renewal, the Core has provided services for 71 different Cancer Center Members, distributed in all 8 of the Scientific Programs. Part of the impact is through generation of preliminary data and grant support (letters of support;sections of grants;sections for manuscripts;slides for presentations), and the GEGF has played an important role in: determining in vivo targets of the 15-PGDH colon cancer tumor suppressor pathway;identifying CAN genes (Candidate Cancer Genes) in colon cancer;and determining a candidate list of genes involved in conferring resistance or sensitivity to hepatocellular carcinoma in mice fed a high fat diet.
The Case Comprehensive Cancer Center is Northeast Ohio's only NCI designated comprehensive cancer center providing bench-to-bedside medical research involving partnerships between basic, clinical and population scientists to speed translation of laboratory discoveries into new prevention/intervention and cancer treatments.
|Li, Jiayang; Gresham, Kenneth S; Mamidi, Ranganath et al. (2018) Sarcomere-based genetic enhancement of systolic cardiac function in a murine model of dilated cardiomyopathy. Int J Cardiol 273:168-176|
|Enane, Francis O; Saunthararajah, Yogen; Korc, Murray (2018) Differentiation therapy and the mechanisms that terminate cancer cell proliferation without harming normal cells. Cell Death Dis 9:912|
|Lennon, Donald; Solchaga, Luis A; Somoza, Rodrigo A et al. (2018) Human and Rat Bone Marrow-Derived Mesenchymal Stem Cells Differ in Their Response to Fibroblast Growth Factor and Platelet-Derived Growth Factor. Tissue Eng Part A 24:1831-1843|
|Evans, Daniel R; Venkitachalam, Srividya; Revoredo, Leslie et al. (2018) Evidence for GALNT12 as a moderate penetrance gene for colorectal cancer. Hum Mutat 39:1092-1101|
|Augestad, Knut M; Keller, Deborah S; Bakaki, Paul M et al. (2018) The impact of rectal cancer tumor height on recurrence rates and metastatic location: A competing risk analysis of a national database. Cancer Epidemiol 53:56-64|
|Chen, Lechuang; Feng, Zhimin; Yue, Hong et al. (2018) Exosomes derived from HIV-1-infected cells promote growth and progression of cancer via HIV TAR RNA. Nat Commun 9:4585|
|Patel, Rutulkumar; Zhang, Luchang; Desai, Amar et al. (2018) Mlh1 deficiency increases the risk of hematopoietic malignancy after simulated space radiation exposure. Leukemia :|
|Lager, Angela M; Corradin, Olivia G; Cregg, Jared M et al. (2018) Rapid functional genetics of the oligodendrocyte lineage using pluripotent stem cells. Nat Commun 9:3708|
|Patel, Rutulkumar; Qing, Yulan; Kennedy, Lucy et al. (2018) MMR Deficiency Does Not Sensitize or Compromise the Function of Hematopoietic Stem Cells to Low and High LET Radiation. Stem Cells Transl Med 7:513-520|
|Desai, Amar; Zhang, Yongyou; Park, Youngsoo et al. (2018) A second-generation 15-PGDH inhibitor promotes bone marrow transplant recovery independently of age, transplant dose and granulocyte colony-stimulating factor support. Haematologica 103:1054-1064|
Showing the most recent 10 out of 1227 publications